BioScrip Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
SunTrust Downgrades BioScrip (BIOS) to Neutral
August 11, 2015 7:15 AM EDTSunTrust Robinson Humphrey downgraded BioScrip (NASDAQ: BIOS) from Buy to Neutral with a price target of $2.00 (from $5.00).
For an analyst ratings summary and ratings history on BioScrip click here. For more ratings news on BioScrip click here.
Shares of BioScrip closed at $2.08 yesterday.
... MoreBioScrip (BIOS) Posts Q2 GAAP Loss of $3.60/Share; Will Review Strategic Alternatives
August 10, 2015 7:06 AM EDTBioScrip (NASDAQ: BIOS) reported Q2 EPS of ($3.60), which may not compare with the analyst estimate of ($0.08). Revenue for the quarter came in at $262.4 million versus the consensus estimate of $269.38 million.
Consolidated Adjusted EBITDA was a loss of $2.5 million, a $13.5 million decrease compared to Adjusted EBITDA of $11.0 million in the prior year period. The decrease was primarily due to a lower gross margin revenue mix shift as well as the increase of contractual and bad debt expense; and
BioScrip announced a multi-step plan to enhance shareholder value, improve financial flexibility and position... More
